written on 28.05.2014

World MS Day: Recent Trials with Investigational Agents for MS


Multiple sclerosis (MS) is chronic, inflammatory, demyelinating disease of the central nervous system that is pathologically characterized by demyelination and neurodegeneration, resulting in the accumulation of irreversible disabilities such as muscle weakness, visual disturbances and other neurological impairments. MS is an extremely variable illness, ranging in severity from relatively benign to devastating. In the most […]